Jérôme de Seze

28PUBLICATIONS
173CO-AUTHORS
PharmacogenomicsGene and molecular therapyNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 23, 2026
Potential sphenopalatine ganglion block efficacy as an alternative to epidural bloodpatch for post-dural puncture headache: a monocentric french study.

|Oct 23, 2026
DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.

|Oct 08, 2026
Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody-Positive NMOSD: Insights From PREVENT and CHAMPION-NMOSD.

|Sep 26, 2026
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.

|Sep 10, 2026
Early switching to ofatumumab avoids a rebound effect after natalizumab cessation in multiple sclerosis patients.

|Aug 04, 2026
French expert opinion on the long-term management of relapsing multiple sclerosis with cladribine tablets beyond year 4.

Pageof 5

Frequent Collaborators

9 joint publications

Jonathan Ciron

8 joint publications

David-Axel Laplaud

8 joint publications

Eric Thouvenot

8 joint publications

Bertrand Bourre